Cargando…
Systematic review of efficacy of direct oral anticoagulants and vitamin K antagonists in left ventricular thrombus
AIMS: Left ventricular thrombus (LVT) increases the risk of thrombotic events and mortality. Vitamin K antagonists (VKAs) used to treat LVT have several known risks, as a result of which direct oral anticoagulant (DOAC) use has recently increased. We aimed to evaluate the safety and efficacy of DOAC...
Autores principales: | Huang, Lei, Tan, Yuan, Pan, Yilong |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
John Wiley and Sons Inc.
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9715875/ https://www.ncbi.nlm.nih.gov/pubmed/35894752 http://dx.doi.org/10.1002/ehf2.14084 |
Ejemplares similares
-
Direct oral anticoagulants compared to vitamin K antagonist for the management of left ventricular thrombus
por: Iqbal, Hansa, et al.
Publicado: (2020) -
Therapeutic efficacy of direct oral anticoagulants and vitamin K antagonists for left ventricular thrombus: Systematic review and meta-analysis
por: Kitano, Tetsuji, et al.
Publicado: (2021) -
Trial sequential analysis of efficacy and safety of direct oral anticoagulants and vitamin K antagonists against left ventricular thrombus
por: Kitano, Tetsuji, et al.
Publicado: (2023) -
Assessment of non‐vitamin K antagonist oral anticoagulants for the management of left ventricular thrombus
por: Li, Shunhui, et al.
Publicado: (2021) -
Meta-analysis comparing direct oral anticoagulants versus vitamin K antagonists in patients with left ventricular thrombus
por: Kido, Kazuhiko, et al.
Publicado: (2021)